Olema Oncology to Participate at Upcoming Investor Conferences
SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq:OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that the Company will present at the following upcoming investor conferences:
Related news for (OLMA)
- Breaking News: MoBot’s Latest Update as of 09/05/25 12:00 PM
- Today’s Top Performers: MoBot’s Market Review 09/05/25 11:00 AM
- Olema Oncology to Participate in Upcoming Investor Conferences
- Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Olema Oncology Nominates OP-3136, an Orally Bioavailable KAT6 Inhibitor, as a Development Candidate